GlassScriptPhysician profile
Paul Tannous
NPI 1023250511
$7,212.87
in general payments reported to CMS, 2019-2025
9 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $228 · 2021: $189 · 2022: $626 · 2023: $2,529 · 2024: $1,496 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,444 · Food and Beverage: $1,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,444.27 |
| Food and Beverage | $1,955.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,769.87 | 2021-2025 | Harmony, Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,715.99 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $482.96 | 2019-2025 | Gore Cardioform Asd Occluder |
| Zoll Medical Corporation | $90.11 | 2019 | |
| Renata Medical, INC. | $60.73 | 2025 | Minima Stent System - 8mm, Minima Stent System - 6mm |
| B. Braun Interventional Systems INC. | $29.63 | 2019 | |
| Okami Medical, INC. | $28.95 | 2025 | Lobo |
| Terumo Medical Corporation | $21.24 | 2019 | |
| Livanova USA, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Tannous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.